Surrozen is a biotechnology company focused on developing therapeutics that modulate the Wnt signaling pathway for tissue repair and regeneration. Its research programs target diseases in areas such as liver, eye, hearing, and other organ systems.
No data available
Are you interested in the impact of this company or this ETF?
It seems we haven't collected any data here yet. Just let us know and we will try to find data as soon as possible. Thank you for your feedback!